Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Cufbolik DMR Tablet

Prescription Icon
Prescription Required

Marketer

Fibovil Pharmaceuticals Pvt Ltd

Salt Composition

Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)

Overview Cufbolik DMR Tablet

Combiflu DMR tablets effectively manage common cold and cough symptoms. This medication offers rapid relief from runny nose, nasal congestion, sneezing, watery eyes, and general stuffiness. Combiflu DMR tablets are administered as directed by a physician, with or without food, in a dosage tailored to individual needs and response. Consistent use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and potential worsening of the condition. Complete disclosure of all other medications to your healthcare provider is essential, as interactions may occur. Possible side effects, including headache, drowsiness, blurred vision, vomiting, diarrhea, dry mouth, and nausea, are usually transient. Report any concerning side effects immediately. Due to potential drowsiness, refrain from driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided to prevent increased drowsiness. Self-medication and sharing medication are strongly discouraged. Adequate fluid intake is recommended. Inform your doctor of pregnancy, pregnancy plans, breastfeeding, or any kidney or liver conditions to ensure appropriate dosage.

Primary Ingredients of Cufbolik DMR Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Cufbolik DMR Tablet

Managing dry cough and the common cold

Major Benefits of Cufbolik DMR Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cufbolik DMR Tablet can be administered with or without food, though consistent timing is recommended.

Common Side effects of Cufbolik DMR Tablet:

  • Sedation
  • Double vision
  • Vomiting
  • Diarrhea
  • Dryness in mouth
  • Nervousness
  • Headache
  • Nausea
  • Decreased appetite
  • Heartburn
  • Dizziness
  • Weakness
  • Discomfort when urinating
  • Polyuria
  • Urinary retention
  • Insomnia (difficulty in sleeping)
  • Hallucination
  • Convulsion

How to use Cufbolik DMR Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cufbolik DMR Tablet can be administered with or without food, although consistent timing is recommended.

How Cufbolik DMR Tablet works:

Tri-Med Relief tablets combine phenylephrine, chlorpheniramine maleate, and dextromethorphan hydrobromide to address common cold symptoms. Phenylephrine constricts blood vessels in the nasal passages, relieving congestion. Chlorpheniramine maleate counteracts allergic responses, alleviating symptoms such as nasal discharge, watery eyes, and sneezing. Dextromethorphan hydrobromide acts as a cough suppressant by diminishing the brain's cough reflex.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when drinking alcohol while taking Cufbolik DMR Tablets. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Cufbolik DMR Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Cufbolik DMR Tablet while breastfeeding is likely inadvisable. Available evidence from humans indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Cufbolik DMR Tablet.

KidneyKidneySAFE IF PRESCRIBED

The use of Cufbolik DMR Tablet in patients with kidney disease appears to pose minimal risk. Existing evidence indicates dose modification may not be necessary, but physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Cufbolik DMR Tablets due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Cufbolik DMR Tablet :

Should you forget a Cufbolik DMR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cufbolik DMR Tablet

LabelValue
Developing Habits No.
Treatment Category Breathing

FAQs on Cufbolik DMR Tablet

Cufbolik DMR Tablet can cause drowsiness or sleepiness, potentially affecting your ability to perform daily tasks. Refrain from driving, operating machinery, working at heights, or engaging in hazardous activities until you understand the medication's effects on you. Report any drowsiness or sleep episodes to your doctor.
Increasing your dosage beyond the recommended amount won't necessarily improve results; it could instead lead to severe side effects and toxicity. If your symptoms worsen despite taking the prescribed dose, seek medical advice for reassessment.
Breastfeeding while taking Cufbolik DMR Tablets, which contain the antihistamine chlorpheniramine, is not recommended. Chlorpheniramine may pass into breast milk, potentially harming your baby. If prescribed this medication, inform your doctor you are breastfeeding.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Cufbolik DMR Tablet
62
MRP 72
13% off